LAKE FOREST, Calif, Jan. 13, 2020 (GLOBE NEWSWIRE) — ToughBuilt Industries, Inc. (“ToughBuilt”) (NASDAQ: TBLT; TBLTW) is an advanced product design, manufacturer and distributor with emphasis on innovative products, currently focused on tools and other accessories for the professional and do-it-yourself construction industries. ToughBuilt today announced that its total gross sales for 2019 exceeded $20.0 million […]

SHELTON, CT / ACCESSWIRE / January 9, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) a company with novel platform technology to treat difficult and life-threatening viral diseases, announces that it has successfully completed genetic toxicology testing required to support the IND application for NV-HHV-101 moving towards human clinical trials. NV-HHV-101 was found to be safe […]

Avivagen Inc. (TSXV:VIV, OTCQB: VIVXF) (“Avivagen”), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, is pleased to announce that it has qualified to trade its common shares in the United States on the OTCQB® Venture Market (“OTCQB®”). Avivagen will begin trading on the […]

NEW YORK, NY / ACCESSWIRE / January 8, 2020 / CTI Industries Corporation (NASDAQ:CTIB) (“CTI” or the “Company”) announced today that the Company has completed the transition of its Chief Executive Officer position to Frank Cesario from Jeffrey Hyland, who recently resigned for personal reasons. During December 2019, Mr. Hyland, who has been President of the […]

SHELTON, CT / ACCESSWIRE / January 7, 2020 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”) a company with novel platform technology to treat difficult and life-threatening viral diseases, announces that it has contracted and initiated genetic toxicology testing required to support the IND application for NV-HHV-101 moving towards human clinical trials. The Company previously contracted an […]

SHELTON, CT / ACCESSWIRE / January 6, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a global leader in nanomedicines against viruses, reports that it has received a cash infusion of $2.25 Million in two different transactions in December, 2019. The Company consummated a debt facility of $2 Million provided by Dr. Anil R. Diwan, its […]

IN YEAR OVER YEAR SALES IN U.K.

Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, is pleased to announce the successful completion of a non-brokered private placement (the “Offering“), issuing 2,500,000 units (the “Units“) at an issue price of $0.50 per Unit for […]

of $5M Strategic Investment from its Largest Shareholder